Pharmaceutical

Filter

Current filters:

None

Popular Filters

6676 to 6700 of 7206 results

Generic competition for Lexapro/Cipralex hits Lundbeck's first-quarter

02-05-2012

Danish drugmaker Lundbeck (LUND: DC) yesterday posted a 33% plunge in first-quarter 2012 net profit to…

CipralexFinancialLexaproLundbeckPharmaceutical

BioAlliance Pharma updates on Amep biotherapy development

02-05-2012

its application for a Phase I/II clinical trial with Amep in the metastatic melanoma, and the signing…

AmepBioAlliance PharmaOncologyPharmaceuticalResearch

Ulcerative colitis drug market to reach $3 billion by 2020

02-05-2012

The ulcerative colitis drug market will experience moderate growth over the next decade, increasing from…

Gastro-intestinalsHumiraMarkets & MarketingPharmaceuticalRemicadeSimponi Injectiontofacitinibvedolizumab

Patient perspectives influencing drug development

02-05-2012

Support is growing for increased collaboration between pharmaceutical companies and patients in research…

BiotechnologyPharmaceuticalRegulationResearch

Pfizer's 1st-qtr net profits dive on generic competition

02-05-2012

Global pharma behemoth Pfizer (NYSE: PFE) reported financial results for first-quarter 2012, with revenues…

FinancialPfizerPharmaceutical

Avastin and Lucentis equivalent in treating age-related macular degeneration

02-05-2012

At two years, the cancer drug Avastin (bevacizumab) and the ophthalmic agent Lucentis (ranibizumab injection),…

AvastinLucentisNovartisOphthalmicsPharmaceuticalResearchRoche

Arzerra and ospemifene NDAs submitted in Japan

02-05-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) and Danish company Genmab A/S (OMX: GEN) have submitted a…

ArzerraAsia-PacificGenmabGlaxoSmithKlineOncologyospemifenePharmaceuticalQuatRx PharmaRegulationShionogiWomen's Health

US Pharma support for Affordable Care Act will total around $90 billion through 2020

01-05-2012

The annual fees related to the US Affordable Care Act which will be levied on drug manufacturers will…

FinancialHealthcareNorth AmericaPharmaceutical

Ukraine to introduce reference pricing and plans for prescription system

01-05-2012

The Ukraine Ministry of Health and domestic producers of pharmaceuticals have signed a memorandum of…

EuropeGenericsHealthcarePharmaceuticalPricingRegulation

US FDA delays Salix' Crofelemer approval

01-05-2012

US drugmaker Salix Pharmaceuticals (Nasdaq: SLXP) revealed yesterday that the Food and Drug Administration…

crofelemerGastro-intestinalsNorth AmericaPharmaceuticalRegulationSalix Pharmaceuticals

Novo Nordisk in-licenses drug delivery technology from Caisson

01-05-2012

Danish insulin giant Novo Nordisk (NVO: N) has entered into a development and license agreement with…

Caisson BiotechHeparinexLicensingNovo NordiskPharmaceutical

New business model to relaunch the BioPharma industry, from ADL

01-05-2012

Traditionally, clinical diagnoses and treatments have focused on diseases and cures. For every ailment,…

BiotechnologyManagementMarkets & MarketingPharmaceutical

Astellas partners with Drais to develop its ulcerative colitis compound

01-05-2012

apanese drug major Astellas Pharma (TYO: 4503) has entered into a uniquely structured partnership with…

Astellas PharmaDrais PharmaceutialsGastro-intestinalsLicensingPharmaceuticalTelsar Pharma

BTG debuts Voraxaze in the USA

01-05-2012

The US subsidiary of the UK-based BTG (LSE: BGC) yesterday announced the launch of Voraxaze (glucarpidase)…

ASD HealthcareBTGMarkets & MarketingNephrology and HepatologyNorth AmericaPharmaceuticalVoraxaze

MannKind licenses novel BTK inhibitors to Tolero Pharma

01-05-2012

USA-based MannKind Corp (Nasdaq: MNKD) has granted an exclusive worldwide license to privately-held Tolero…

Inflammatory diseasesLicensingMannKindOncologyPharmaceuticalTolero Pharmaceuticals

Faes Farma and Menarini unit link to commercialize bilastine in Asia-Pacific

30-04-2012

Spanish drugmaker Faes Farma (FAE: SM) and Invida Holding, part of family owned Italian drugmaker Menarini,…

Asia-PacificbilastineFaes FarmaInvidaLicensingMenariniPharmaceuticalRespiratory and Pulmonary

Two drugs better than one to treat youth with type 2 diabetes

30-04-2012

A combination of two diabetes drugs, metformin and rosiglitazone (the active ingredient of GlaxoSmithKline's…

AvandiaDiabetesmetforminPharmaceuticalResearchrosiglitazone

Haemonetics to buy Pall Corp blood collection and processing lines for $550 million; and Hemerus Medical

30-04-2012

USA-based Pall Corp (NYSE: PLL) has entered into an agreement to sell certain assets of its blood collection,…

HaemoneticsHemerus MedicalMergers & AcquisitionsPall CorpPharmaceutical

Biopharmaceuticals "no longer a growth market" in Germany

30-04-2012

After years of consistent growth, the German biopharmaceuticals market came to a juddering halt last…

BiotechnologyEuropeMarkets & MarketingPharmaceuticalPoliticsPricingRegulation

Merck & Co 1st-qtr earnings just beat expectations; wins Mylan patent dispute

30-04-2012

US drug giant Merck & Co sales that global sales in the first-quarter of 2012 increased 1% to $11.7 billion,…

FinancialLegalMerck & CoMylan LaboratoriesNorth AmericaPatentsPharmaceuticalVytorinZetia

US FDA clears new ED drug Stendra

30-04-2012

The US Food and Drug Administration late Friday gave its approval for drug developer Vivus (Nasdaq: VVUS)…

avanafilMen's HealthNorth AmericaPharmaceuticalRegulationReproductiveStendraVivus

6676 to 6700 of 7206 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top